Usually, combined therapies consist of adding atropine in different concentrations to optical therapy, aiming to improve the efficacy of myopia control. The presentation reviews the results of recent studies on combined therapies – mainly atropine plus orthok, soft multifocal contact lenses and myopia control spectacles. The second part copes with practical facts – when to use combined therapy, how to deal with high risk patients, and possible issues, with clinical examples from my practice. Combined therapies are an option for children with progression on monotherapy, as well as a valuable alternative, especially in children with fast progression and risk of high myopia.